SynInnova Laboratories Inc.

SL-2799

Baricitinib-d₄, >98% (CP)

Isotopic Purity :

98 atom % D

CAS No. :

[1564241-99-1]

Synonyms : 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile-d₄; INCB028050-d₄; LY3009104-d₄

Price and Availability
Pack Size	Price in USD	Quantity	Availability	Shipping Status
5MG	1980.00	- +	Back Order	Estimated to Ship on 02.01.2025
10MG	3480.00	- +	Back Order	Estimated to Ship on 02.01.2025

Chemical Properties
Mol. Formula : C₁₆H₁₃D₄N₇O₂S	Mol. Weight : 375.44
Appearance : Solid	Melting Point : Not available
For Laboratory research use only, not for drug, household or other uses.

Applications : Baricitinib-d4 is a deuterium labelled analog of Baricitinib, which is a a selective and orally bioavailable JAK1 and JAK2 inhibitor for the treatment of rheumatoid arthritis. Also, this is a COVID-19 related research chemical.

References : Fridman J. S. et al. J. Immunol., 184 (9), 5298-5307, 2010; Jabbari A. et al. EBioMedicine. 2 (4), 351-5, 2015; Khan I. M. et al. Int. J. Obes (Lond). 39 (11), 1607-1618, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-2799

Product Name : Baricitinib-d₄

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!

Related Products

SI-1064	Baricitinib
SL-2805	Baricitinib impurity 5
SL-2802	Baricitinib impurity 2
SL-2803	Baricitinib impurity 3
SL-2801	Baricitinib impurity 1
SL-2799	Baricitinib-d₄
SL-2806	(1,5-Bis(1-ethoxyethyl)-1H-pyrazol-4-yl)boronic acid pinacol ester
SL-2800	Baricitinib-d₅
SL-2807	(1,3-Bis(1-ethoxyethyl)-1H-pyrazol-4-yl)boronic acid pinacol ester
SL-2804	Baricitinib impurity 4

SL-2799	Baricitinib-d₄
SL-3020	2’-Deschloro-2’-hydroxy dasatinib
SI-4824	6-Bromo-4-((trans)-4-methoxycyclohexyl)methyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one
SI-1829	Ethyl 3-amino-1H-pyrrole-2-carboxylate
SA-1270	5-(4-Methylpiperazin-1-yl)-2-nitroaniline
SL-4902	(S)-9-Hydroxyrisperidone-d₄
SL-6495	Fexofenadine-d₆
SL-2331	Verapamil EP impurity D
SA-404	3-Carboxy-2-fluorobenzeneboronic acid pinacol ester
SI-1739	Ethyl 4-isopropyl-5-(4-pyridyl)-4H-1,2,4-triazole-3-carboxylate
SL-2804	Baricitinib impurity 4
SL-5734	Megestrol acetate EP impurity C

SL-2799

Baricitinib-d4, >98% (CP)

Recently Viewed Products

Related Products

Baricitinib-d₄, >98% (CP)